Covalon Technologies (OTCMKTS:CVALF) Trading Up 4.7%

Shares of Covalon Technologies Ltd. (OTCMKTS:CVALF) traded up 4.7% during mid-day trading on Thursday . The stock traded as high as $0.89 and last traded at $0.89. 400 shares were traded during trading, a decline of 93% from the average session volume of 5,577 shares. The stock had previously closed at $0.85.

Covalon Technologies Price Performance

The business’s 50-day moving average price is $0.87 and its two-hundred day moving average price is $0.91. The company has a market capitalization of $22.24 million, a price-to-earnings ratio of -5.91 and a beta of -0.56.

Covalon Technologies (OTCMKTS:CVALF) last announced its quarterly earnings data on Wednesday, February 28th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $3.43 million during the quarter. Covalon Technologies had a negative net margin of 19.70% and a negative return on equity of 23.88%.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.